1Glaspy J , Cavill I. Role of iron in optimizing responses of anemic cancer patients to erythropoietin. ()neology, 1999, 13 (4) :461-473.
2Coiffer B, Guastalla P, Pujade-Lauraine E, et al. Predicting cancer-associated anaemia in patients receiving non-platinum ehemotherapy:results of a retrospective survey. Eur J Cancer, 2001,37(13) :1617-1623.
7Ludwig H,Van Belle S,Barrett-Lee P,et al.The European Cancer Anemia Survey(ECAS):A large,multinational,prospective survey defining the prevalence,incidence,and treatment of anemia in cancer oatients.Eur J Cancer,2004,40(15):2293-2306.
8Harrison L B,Shasha D,White C,et al.Radiotherapy-associated anemia:The scope of the problem.Oncologist,2005(S2): 1-7.
9Pehlivan B,Zouhair A,Luthi F,et al.Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy.Ann Surg Oncol,2009,16(5):1331-1336.
10Milano M,Schneider M.EPO in cancer anemia:benefits and potential risks.Clinical Reviews in Oncology,2007,62(2): 119-125.
